// startup autopsy
Zyraz Technology
Malaysia's biotech ambition that ran out of runway
marketfitSlow Death
Years-long decline before final shutdown · Fatal mistake: Zyraz failed to build commercial-stage products suited to Malaysian healthcare buyers, burning through funding on R&D without generating sustainable revenue.
Key Events Timeline
FOUNDING
Zyraz Technology founded in Malaysia to pursue biotech R&D opportunities in Southeast Asia.
FUNDING
Zyraz secures a significant funding round to expand its biotech pipeline and laboratory capabilities.
FUNDING
Final funding round closes at $15.4M total raised; investors grow cautious about lack of commercial products.
LAYOFF
Zyraz begins downsizing R&D staff as cash reserves dwindle and no new funding materializes.
SHUTDOWN
Zyraz Technology ceases operations after failing to commercialize its biotech assets or secure additional investment.